70 related articles for article (PubMed ID: 20459048)
1. [Effects of differentially expressed proteins in hepatocellular carcinoma cell treated by different telomerase inhibitors].
Wei X; Zhang Z; He M; Wang X; Zheng W
Wei Sheng Yan Jiu; 2010 Mar; 39(2):242-5. PubMed ID: 20459048
[TBL] [Abstract][Full Text] [Related]
2. [Effects of 3'-azido-deoxythymidine on telomerase activity and protein expression of hepatocarcinoma cell line SMMC-7721].
He M; Jiang YY; Zhu M; Wei X; Qin J; Zhang ZY; Li L
Ai Zheng; 2006 May; 25(5):543-8. PubMed ID: 16687071
[TBL] [Abstract][Full Text] [Related]
3. [Epigallocatechin-3-gallate induces apoptosis in human hepatocellular carcinoma cells].
Chen XL; Wang Q; Cao LQ; Huang XH; Fu XH; Tan HX; Zhen MC; Chen JS
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2524-8. PubMed ID: 19080641
[TBL] [Abstract][Full Text] [Related]
4. Synergistic down-regulation of telomerase by all-trans retinoic acid and antisense oligonucleotide in oral squamous cell carcinoma cell line (Tca8113).
Zhang P; Xu Q; Chen WT; Duan LQ; Zhang ZY; Zhou XJ
Oral Oncol; 2005 Oct; 41(9):909-15. PubMed ID: 16051514
[TBL] [Abstract][Full Text] [Related]
5. [Screening of differentially expressed proteins associated with directional highly lymphatic metastasis in ovarian carcinoma cell lines using SELDI-TOF-MS technology].
Guan X; Li DR; Wang Q; Li L; Ruan HY; Zhang W
Ai Zheng; 2008 Nov; 27(11):1155-60. PubMed ID: 19000445
[TBL] [Abstract][Full Text] [Related]
6. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma.
Kunisada M; Budiyanto A; Bito T; Nishigori C; Ueda M
Br J Dermatol; 2005 Mar; 152(3):435-43. PubMed ID: 15787811
[TBL] [Abstract][Full Text] [Related]
8. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of human telomerase reverse transcriptase RNAi which increases hepatocellular carcinoma cell apoptosis induced by TRAIL].
Zhang RG; Fang DC; Ning XY; Wang GA
Zhonghua Gan Zang Bing Za Zhi; 2007 Jan; 15(1):32-6. PubMed ID: 17244456
[TBL] [Abstract][Full Text] [Related]
10. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
11. [Effect of nanosize delivery system for ASODN against hTERT on the expression of telomerase in the esophageal cancer EC9706 cells].
Wang J; Zhang ZZ; Zhou TY; Liu YQ; Li HX
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):566-72. PubMed ID: 19102931
[TBL] [Abstract][Full Text] [Related]
12. Liver-specific gene therapy of hepatocellular carcinoma by targeting human telomerase reverse transcriptase with pegylated immuno-lipopolyplexes.
Hu Y; Shen Y; Ji B; Yin S; Ren X; Chen T; Ma Y; Zhang Z; Zhang Y
Eur J Pharm Biopharm; 2011 Aug; 78(3):320-5. PubMed ID: 21220007
[TBL] [Abstract][Full Text] [Related]
13. [Effect of telomerase on ginsenoside Rh2-induced differentiation of hepatocarcinoma cell line SMMC-7721].
Zeng XL; Tu ZG
Ai Zheng; 2004 Dec; 23(12):1655-9. PubMed ID: 15601555
[TBL] [Abstract][Full Text] [Related]
14. [Telomerase gene antisense oligodeoxynucleotide down-regulates telomerase activity in HL-60 cells].
He DM; Zhang H
Ai Zheng; 2002 Oct; 21(10):1070-4. PubMed ID: 12508645
[TBL] [Abstract][Full Text] [Related]
15. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
Mittal A; Pate MS; Wylie RC; Tollefsbol TO; Katiyar SK
Int J Oncol; 2004 Mar; 24(3):703-10. PubMed ID: 14767556
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
[TBL] [Abstract][Full Text] [Related]
17. [A DNA vector-based RNAi technology to inhibit the activity of the telomerase of cell line HCCLM3].
Lu XD; Qin WX; Pan DN; Li JJ; Wan DF; Wen CJ; Li CJ; Gu JR; Yang SL
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1381-5. PubMed ID: 15387948
[TBL] [Abstract][Full Text] [Related]
18. RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity.
Zhang PH; Zou L; Tu ZG
J Surg Res; 2006 Mar; 131(1):143-9. PubMed ID: 16298398
[TBL] [Abstract][Full Text] [Related]
19. [The effect of telomerase inhibitors on oral squamous carcinoma cells].
Yang Z; Chen W; Zhang Q
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Jun; 21(3):231-4. PubMed ID: 12898773
[TBL] [Abstract][Full Text] [Related]
20. [Effect of antisense oligodeoxynucleotides of RNA component of human telomerase on cisplatin induced apoptosis in K562 cells].
Xiao Y; Zhang H
Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):144-7. PubMed ID: 12581964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
